FDA Issues Final Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors | Epstein Becker & Green

On August 15, 2023, the U.S. Food and Drug Administration (“FDA”) released final guidance on informed consent for clinical investigations (“Final Guidance”). This update follows FDA’s...

Related Keywords

,Drug Administration ,Epstein Becker ,Informed Consent ,Final Guidance ,